Lantheus Holdings, Inc. (NASDAQ:LNTH) agreed to acquire Evergreen Theragnostics, Inc. in an all-cash transaction involving an ...

Lantheus (LNTH) announced the appointment of Phuong Khanh Morrow, M.D. to Lantheus’ Board of Directors, effective February 1, 2025. As an ...

LNTH Lantheus to Buy Evergreen Theragnostics Lantheus Holdings, Inc. (NASDAQ:LNTH) announced its second acquisition this ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Invest with Confidence: ...

Radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) had some news to report Tuesday morning, but the market ...

In trading on Tuesday, shares of Lantheus Holdings Inc (Symbol: LNTH) crossed below their 200 day moving average of $92.96, changing hands as low as $90.75 per share. Lantheus Holdings Inc shares ...

ClearBridge Small Cap Strategy highlighted stocks like Lantheus Holdings, Inc. (NASDAQ:LNTH), in the third quarter 2024 investor letter. Lantheus Holdings, Inc. (NASDAQ:LNTH) is a company that ...

Lantheus Holdings Inc. is adding to its portfolio yet again, acquiring a clinical-stage radiopharmaceutical company in a deal ...

Massachusetts-based radiopharmaceutical company Lantheus (Nasdaq: LNTH) has announced a plan to acquire clinical-stage ...

The company announced a $350 million acquisition. Get Wall Street's Hottest Chart Every Morning Lantheus Holdings Inc LNTH shares are trading lower by 4.4% to $91.64 during Monday’s session ...

The transaction is expected to be accretive to Lantheus’ Adjusted Earnings Per Share within 12 months of close. Price Action: At last check on Tuesday, LNTH stock was down 5.56% to $92.85.

LNTH has 3 products PLYARIFY, DEFINITY, and TechneLite, all of which are very successful. From my research, I think LTNH can easily become a $200+ stock in the next 3–5 years, which I why I'm ...